Spinal muscular atrophy molecular biology

Revision as of 14:37, 28 January 2012 by Priyamvada Singh (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Spinal Muscular Atrophy Microchapters

Home

Patient Info

Overview

Epidemiology and Demographics

Risk Factors

Screening

Other forms

Molecular Biology

Genetics

Types

Diagnosis

Diagnosis

Full Differential Diagnosis

Symptom

Physical Examination

Electrolyte & Biomarker Studies

Electrocardiogram

Chest X Ray

MRI and CT

Echocardiography or Ultrasound

Other Imaging Findings

Pathology

Other Diagnostic Studies

Treatment

Outcome measures

Therapeutics development

Indications For Surgery

Research

Pre-Operative Assessment

Post-Operative Assessment

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Spinal muscular atrophy molecular biology Resources

Most recent articles on Spinal muscular atrophy molecular biology

Most cited articles on Spinal muscular atrophy molecular biology

Review articles on Spinal muscular atrophy molecular biology

Review articles on Spinal muscular atrophy molecular biology

CME Programs on Spinal muscular atrophy molecular biology

Powerpoint slides on Spinal muscular atrophy molecular biology

Images of Spinal muscular atrophy molecular biology

Ongoing Trials on Spinal muscular atrophy molecular biology at Clinical Trials.gov

US National Guidelines Clearinghouse on Spinal muscular atrophy molecular biology

NICE Guidance on Spinal muscular atrophy molecular biology

FDA on Spinal muscular atrophy molecular biology

CDC on Spinal muscular atrophy molecular biology

Spinal muscular atrophy molecular biology in the news

Blogs on Spinal muscular atrophy molecular biology

Directions to Hospitals Treating Spinal muscular atrophy molecular biology

Risk calculators and risk factors for Spinal muscular atrophy molecular biology

Editors-in-Chief: C. Michael Gibson, M.S., M.D.; Priyamvada Singh, MBBS

Overview

Spinal muscular atrophy is caused by the mutation in SMN1 (survival motor neuron 1)gene. SMN 1 gene produces SMN protein. This protein is ubiquitously found in all cells (located in both the cytoplasm and in the nucleus). The main function that is found to be associated with them are-

  • Components of spliceosome, involved in pre-m-RNA splicing (transcription) [1]
  • Involved in actin cytoskeletal dynamics (motor axon pathfinding)[2]
  • Involved in maintaining structural and physiological integrity of neuromuscular junction [3]

References

  1. Kolb SJ, Battle DJ, Dreyfuss G (2007). "Molecular functions of the SMN complex". J Child Neurol. 22 (8): 990–4. doi:10.1177/0883073807305666. PMID 17761654.
  2. Bowerman M, Anderson CL, Beauvais A, Boyl PP, Witke W, Kothary R (2009). "SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis". Mol Cell Neurosci. 42 (1): 66–74. doi:10.1016/j.mcn.2009.05.009. PMID 19497369.
  3. Rossoll W, Bassell GJ (2009). "Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes". Results Probl Cell Differ. 48: 289–326. doi:10.1007/400_2009_4. PMID 19343312.

Template:WH Template:WS